Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB9UK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,000
Award facts
- Contract value 100% obligated
- $47,000.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,000.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 4, 2026, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a medication used to treat cystic fibrosis. The contract, which is not set aside for any specific business type, represents a competitive award and is scheduled for completion by February 5, 2026. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
AmerisourceBergen Drug Corp operates as a critical pharmaceutical distributor within the federal medical supply chain, serving military healthcare systems, the Defense Health Agency, and other government medical institutions. The company's role under the DLA Troop Support Medical IDC encompasses the delivery of a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Pulmozyme represents a routine fulfillment under the broader pharmaceutical prime vendor arrangement, demonstrating the contractor's ongoing capability to meet federal requirements for essential medications to support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FB9UK?
SPE2DR26FB9UK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FB9UK worth?
The government has obligated $47,000 on SPE2DR26FB9UK.
Is contract SPE2DR26FB9UK an order under another contract?
Yes. SPE2DR26FB9UK is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9UK competed?
The extent of competition for SPE2DR26FB9UK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award